期刊文献+

肝癌细胞系(PLC/PRF/S)的免疫抑因子的分离及其特征

Isolation and characterization of an immunosuppressive factor from a hepatoceliular carcinom a cell line(PLC/PRF/5)
下载PDF
导出
摘要 应用中和人肝癌细胞系(PLC/PRF/5)培养上清抑制NK 活性的单克隆抗体亲和层折从PLC/PRF/5细胞提取液中分离纯化免疫抑制因子。分离的免疫抑制因子电泳分析表明为42KD 的多肽,它抑制PHA 或IL-2刺激正常外周血单个核细胞的~3H 胸腺嘧啶掺入,这种抑制作用随免疫抑制因子浓度的增加(从17μg/ml 到140μg/ml)而增强(抑制率从10%到99%)。在培养中一定量的IL-2能部份或全部消除一定浓度的免疫抑制因子的抑制作用。这一免疫抑制因子还具有抑制PHA 诱导单个核细胞的IL-2表达和抑制NK 活性等生物学特征. From the cell extract of a human hepatoceltular carcinoma cell line (PLC/PRF/5),an im- munosuppressive factor,a polypeptide with a relative molecular mass of 42 KD was isolated byaffinity chromotography with AH- Sepharose 4B coated with a monoclonal antibody whichraised against PLC/PRF/5 cells,and which can neutralize the inhibition of NK activity causedby superna tant of PLC/PRF/5 cell.The factor was characterized by PAGE electrophoresis andWestern Blot analysis.Biological assay showed that the factor isolated suppresses PHA—inducedor IL—2—stimulated ~3H—thymidine uptake of peripheral blood mononuclear ceils (PBM).This suppression was dosedependent,and ranged from 100% to 99% when the concentration ofthe factor varied from 17 μg/ml to 140μg/ml in culture media.However,the suppression of thefactor on PBM in response to IL—2 was decreased by increasing the dose of IL—2 in the cellculture.This factor also suppresses the expression of IL—2 by PHA—induced PBM,as well asthe NK activity of the peripheral blood lymphocytes.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 1993年第1期31-35,共5页 Chinese Journal of Immunology
  • 相关文献

参考文献5

  • 1Hal Hirte,David A. Clark. Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid: Identification of transforming growth factor-β as a suppressive factor[J] 1991,Cancer Immunology Immunotherapy(5):296~302
  • 2Andrew D. Yurochko,Prakash S. Nagarkatti,Mitzi Nagarkatti,Klaus D. Elgert. Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cells[J] 1989,Cancer Immunology Immunotherapy(3):170~176
  • 3Masao Eura,Tatsuhiko Maehara,Tsutomu Ikawa,Takeru Ishikawa. Suppressor cells in the effector phase of autologous cytotoxic reactions in cancer patients[J] 1988,Cancer Immunology Immunotherapy(2):147~153
  • 4Aleta Keong,Jean Herman,Arthur R. Rabson. Supernatant derived from a human hepatocellular carcinoma cell line (PLC/PRF/5) depresses natural killer (NK) cell activity[J] 1983,Cancer Immunology Immunotherapy(3):183~187
  • 5Aleta Keong,Arthur R. Rabson. Supernatant derived from a human hepatocellular carcinoma cell line (PLC/PRF/5) activates a population of T-suppressor cells[J] 1983,Cancer Immunology Immunotherapy(3):178~182

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部